BASDAI Score
Calculate the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) score to assess AS disease activity with six validated symptom questions. Free online medical tool.
About This Calculator
The BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) Score Calculator is a validated clinical tool designed to measure disease activity in patients with ankylosing spondylitis (AS). Developed in 1994 by a multidisciplinary team at the Royal National Hospital for Rheumatic Diseases in Bath, England, the BASDAI has become one of the most widely used patient-reported outcome measures in rheumatology practice and clinical research worldwide.
The BASDAI consists of six questions covering the five major symptom domains of ankylosing spondylitis: fatigue (general tiredness), spinal pain (neck, back, or hip pain related to AS), peripheral joint pain/swelling, enthesitis (areas tender to touch or pressure), and morning stiffness (both severity and duration). Each symptom is rated on a 0–10 visual analog scale (VAS), with 0 representing no problem and 10 representing the most severe problem. The score is calculated using the formula: (Q1 + Q2 + Q3 + Q4 + (Q5 + Q6)/2) / 5, producing a final score ranging from 0 to 10. Because questions 5 and 6 both assess morning stiffness, their scores are averaged before inclusion.
A BASDAI score of 4 or higher is the established threshold indicating suboptimal disease control. Patients scoring 4 or above may benefit from treatment adjustment, including biologic disease-modifying antirheumatic drugs (bDMARDs) such as TNF inhibitors (e.g., adalimumab, etanercept, infliximab) or IL-17 inhibitors (e.g., secukinumab, ixekizumab). The BASDAI is typically assessed at each clinical visit to track disease progression and treatment response over time.
Regional Notes
India: Ankylosing spondylitis affects approximately 0.1–0.5% of the Indian population. The BASDAI is widely used by Indian rheumatologists alongside the ASDAS-CRP score and inflammatory markers. Biologic therapies for AS are available in India through specialty rheumatology centers. The Indian Rheumatology Association recommends regular BASDAI monitoring for patients on biologic therapy to assess treatment response.
United States: In the US, the BASDAI is commonly used in rheumatology practice and is recognized by the American College of Rheumatology (ACR) as a valid disease activity measure. The ACR recommends using the BASDAI or ASDAS for monitoring AS patients. Biologic therapies are often initiated when BASDAI exceeds 4 despite adequate NSAID trials. The BASDAI is also used as an entry criterion and outcome measure in AS clinical trials.
United Kingdom: NICE guidelines recommend the BASDAI for monitoring disease activity in ankylosing spondylitis. In the NHS, a BASDAI score of 4 or higher combined with elevated CRP and failure of standard NSAID therapy typically qualifies patients for biologic treatment under NICE TA383. The BASDAI is measured at baseline and at 12-week intervals during biologic therapy to assess response.
This tool is intended for educational and clinical reference. Always consult a qualified rheumatologist for diagnosis and treatment of ankylosing spondylitis.
Frequently Asked Questions
What is the BASDAI score?
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is a validated diagnostic questionnaire developed in 1994 by a research team at the Royal National Hospital for Rheumatic Diseases in Bath, England. It consists of six questions covering fatigue, spinal pain, joint pain/swelling, areas of tenderness, and morning stiffness (severity and duration) to assess disease activity in patients with ankylosing spondylitis.
How is the BASDAI score calculated?
The BASDAI score is calculated using the formula: (Q1 + Q2 + Q3 + Q4 + (Q5 + Q6)/2) / 5. Each question is scored on a 0–10 scale. Questions 5 (morning stiffness severity) and 6 (morning stiffness duration) are averaged because they both relate to the same symptom. The final score ranges from 0 to 10.
What does a BASDAI score of 4 or higher mean?
A BASDAI score of 4 or greater is generally considered to indicate suboptimal control of disease activity. Patients scoring 4 or more may be good candidates for a change in treatment, may benefit from biologic therapies, and may be candidates for enrolment in clinical trials evaluating new drug therapies for ankylosing spondylitis.
How is the BASDAI score interpreted?
BASDAI scores range from 0 to 10. A score below 4 suggests well-controlled disease activity where current treatment appears adequate. A score of 4 or higher suggests suboptimal disease control, and patients should discuss potential treatment adjustments with their rheumatologist. The BASDAI is typically measured at regular intervals to track disease activity over time.
What are the six questions in the BASDAI?
The BASDAI consists of six questions assessing the past week: 1) Fatigue/tiredness level, 2) AS-related neck, back or hip pain, 3) Pain/swelling in joints other than neck/back/hips, 4) Discomfort from areas tender to touch or pressure, 5) Morning stiffness severity, and 6) Morning stiffness duration (from 0 hours to 2+ hours). Each is rated on a 0–10 scale.
Is the BASDAI score used worldwide?
Yes, the BASDAI is widely used internationally as a standard tool for assessing ankylosing spondylitis disease activity in clinical practice and research. It has been validated in multiple languages and populations. In India, the BASDAI is commonly used by rheumatologists alongside the ASDAS (Ankylosing Spondylitis Disease Activity Score) and inflammatory markers like CRP and ESR for comprehensive disease assessment.
Does BASDAI differ from ASDAS?
Yes. While BASDAI is purely patient-reported (symptom-based), the ASDAS (Ankylosing Spondylitis Disease Activity Score) incorporates both patient-reported outcomes and acute-phase reactants such as C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR). ASDAS is increasingly preferred in clinical trials due to its higher sensitivity to change. Many rheumatologists use both scores in combination.
Can I rely on this calculator for medical decisions?
No. This calculator is for educational and reference purposes only. The BASDAI is a clinical assessment tool and should never replace a comprehensive medical evaluation by a qualified rheumatologist. Always consult a healthcare professional for diagnosis, treatment decisions, and management of ankylosing spondylitis.